Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome

NCT03122652 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Teriflunomide 14 MG Oral Tablet [Aubagio]
DRUG: Placebo Oral Tablet

Sponsor

Centre Hospitalier Universitaire de Nice

Collaborators

[object Object]